Optimization of felodipine nanosuspensions using full factorial design

International Journal of PharmTech Research

Volumn 5, Issue 2, 2013, Pages 553-561

  Sahu, Bhanu P ^a   Das, Malay K ^b  

^a GAUHATI UNIVERSITY   (India)

^b DIBRUGARH UNIVERSITY   (India)

Author keywords

Factorial design; Felodipine; Nanoprecipitation; Nanosuspension

Indexed keywords

FELODIPINE;

ARTICLE; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; FACTORIAL DESIGN; HYDROPHOBICITY; NANOEMULSION; PARTICLE SIZE; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; ULTRASOUND; ZETA POTENTIAL;

EID: 84879163157     PISSN: 09744304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rafati H, Talebpour Z, Adlnasab L. And Ebrahimi S. N, Quality by design: optimization of a liquid filled pH-responsive macroparticles using draper-lin composite design, J. Pharma. Sci., 2009, 1-11.
2. Zidan A S, Sammourb O A, Hammad M. A, Megrab N A, Habib M J, Khana M A, Quality by design: Understanding the formulation variables of acyclosporine a self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int. J. Pharm., 2007,332, 55-63.
3. Singh B, Chakkal S, Ahuja N, Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology, AAPS PharmSciTech, 2006,7, 19-28.
4. 2 full factorial design, Int.J. PharmTech Res., 2009. 1(3), 644-653.
5. Saltiel E, Ellrodt A G, Monk J P, Langley M S, Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs,1988, 36, 387-42.
6. Wingstrand K, Abrahamson B, Edgar B, Bioavailability from felodipine extended-release tablets with different dissolution properties. Int. J. Pharm., 1990. 60, 151-156.
7. Kerc J, Srcic S, Mohar M, Smid-Korbar J, Some physicochemical properties of glassy felodipine. Int. J. Pharm., 1991. 68, 25-33.
8. Kim B K, Hwang S J, Park J B, Park H J, Characteristics of felodipine-located poly(e-caprolactone) microspheres J. Microenc., 2005. 22,193-203.
9. Lee D W, Hwang S J, Park J B, Park H J, Preparation and release characteristics of polymer-coated and blended alginate microspheres. J. Microenc., 2003, 20, 179-192.
10. Dong-Han W, Min-Soo K, Sibeum L, Jeong-Sook P, Sung-Joo H, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int.J. Pharm.,2010, 301, 199-208.
11. Kesisoglou F, Panmai S, Wu Y, Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev., 2007, 59, 631-644.
12. Patravale V B, Date A A, Kulkarni R M, Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol.,2004,56, pp. 827-840.
13. Rabinow BE, Nanosuspensions in drug delivery. Drug Discov,2004, 3:785-796.
14. Fessi H, Puissieux F, Devissaguet J P, Thies C, Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. 1988, US Patent US5118528, 2.
15. Quintanar-Guerrero D, Alĺemann E, Fessi H, Doelker E, Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 1998, 24, 1113-1128.
16. Bilati U, Allemann E, Doelker E, Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles, Eur. J. Pharm. BioPharm., 2005. 24, 67-75.
17. Patel D J, Patel J K, Pandya V M, Jivani R R, Patel R D, Optimization of Formulation Parameters on Famotidine Nanosuspension Using Factorial Design and the Desirability FunctionInt.J. PharmTech Res., 2010.2(1), 155-161.
18. Yuancai D, Wai K N, Jun H, Shoucang S, Reginald B.H. T, A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int. J Pharm,2010,386, 256-261.
19. Yadav K S, Sawant K K, Modified Nanoprecipitation Method for Preparation of Cytarabine-Loaded PLGA Nanoparticles AAPS PharmSciTech,2010,11(3): 1456-1465.